Navigation Links
RedVision Announces Integrated Client Workflow Platform: TitleVision2 'The Power of Two'

PARSIPPANY, N.J., April 27 /PRNewswire/ -- RedVision, a national provider of real property research solutions announced today the release of TitleVision2, a fully integrated production workflow solution for lenders, title underwriters, title agents, and default servicing professionals.

TitleVision2 is changing the way the real property research industry compiles, prepares and delivers real property reports and title examinations. This unique platform empowers RedVision clients to integrate and customize workflow tasks and production roles based on their individual needs. RedVision is turning high touch processes into automated functions by leveraging real estate data, ground breaking technology and more than 450 U.S. based employees and examiners.

"We are proud of our technology and the savings TitleVision2 provides each of our clients," said Brian Twibell, CEO of RedVision. "By integrating our production platform and experienced staff with our clients we enable each of them to utilize RedVision's professionals and make the best use of their staff. We are providing peace of mind that every touch point of a property report receives the highest skill level possible and quality standards are exceeded every step of the way. Creating a true strategic partnership is an unwavering goal for RedVision."  

TitleVision2 was created with "The Power of Two" in mind and the need to provide clients with reliable means to dealing with industry cycles and cost saving alternatives. The systems foundation was built from the RedVision geographically indexed title plant "TitleVision" and the internal production platform utilized by RedVision's staff. The key purpose behind the development of TitleVision2 was to supply clients with a solution for cost effective staffing and high quality reports. The system addresses an industry reality that staffing and production needs can change by the hour. At a moment's notice, clients can now select online access to the company's robust title plant while utilizing their own examination staff, or have access to the RedVision research and examination team. Clients can now completely customize the vendor relationship from order placement and research needs, to typing requirements and quality control standards all at the click of a button.

About RedVision

RedVision is an independent provider of real property research solutions, combining experts and technology to improve service levels and the bottom line. RedVision serves users of title evidence looking for relevant and accurate information to make sound business decisions relating to real property transactions. The company's revolutionary approach combines a distributed services workflow platform, a vast title plant database, and well-trained service experts to provide accurate, cost effective, and timely real property research services for its banking, title, and default and settlement service customers.

SOURCE RedVision
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/25/2015)... Calif. , Nov. 25, 2015  Amgen (NASDAQ: ... Biologics License Application (BLA) with the United ... for ABP 501, a biosimilar candidate to Humira ® ... adalimumab biosimilar application submitted to the FDA and represents ... Sean E. Harper , M.D., executive vice ...
(Date:11/25/2015)... 2015 AAIPharma Services Corp./Cambridge Major Laboratories, ... least $15.8  Million to expand its laboratories and ... . The expansion will provide additional office space ... demands of the pharmaceutical and biotechnology markets. ... provide up to 40,000 square feet of expanded ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... ... Jobs in hospital medical laboratories and in the imaging field lead the many ... Medical Group . These fields, as well as travel nursing, ranked at ... through the company’s website, , The leading healthcare staffing agency released ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings ... with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired ... font, giving users limitless opportunities to stylize and create designs quickly and easily, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast ... found on mammography, according to a study published online in the journal Radiology. ... on mammography may necessitate a change in treatment. , Breast MRI is the ...
(Date:11/25/2015)... MN (PRWEB) , ... November 25, 2015 , ... Finnleo, ... through Christmas Eve on several models of traditional and far-infrared saunas. , ... Nordic Spruce is the most traditional Finnish sauna wood, and Finnleo uses only European ...
(Date:11/25/2015)... ... 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever ... with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the ... the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is ...
Breaking Medicine News(10 mins):